Proteotoxicity to Inflammation & Dementia

This feed focuses on the contribution of aging-associated proteotoxicity to inflammation and neurodegenerative disorders, including Alzheimer’s and dementia. Discover the latest research here.

May 22, 2020

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Melissa PetersenSid E O'Bryant
May 24, 2020

Inflammation and oxidative stress induced by lipid peroxidation metabolite 4-hydroxynonenal in human corneal epithelial cells

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Hui LiuShaozhen Zhao
June 4, 2020

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Sid E O'BryantNicole Schupf
May 24, 2020
Preprint
Open Access

A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection

medRxiv
F. L. van de VeerdonkL. A. B. Joosten
May 30, 2020

The mouse heart mitochondria N terminome provides insights into ClpXP-mediated proteolysis

Molecular & Cellular Proteomics : MCP
Eduard HofsetzPitter F Huesgen
May 29, 2020
Review

Neuron-Glia interaction: Molecular basis of Alzheimer's Disease and Applications of Neuroproteomics

The European Journal of Neuroscience
Abdallah Mohammad IbrahimJb Senthil Kumar
May 28, 2020

Itch attenuates CD4 T cell proliferation in mice by limiting WBP2 protein stability

European Journal of Immunology
Natania S FieldPaula M Oliver
June 4, 2020
Open Access

A fully joint Bayesian quantitative trait locus mapping of human protein abundance in plasma

PLoS Computational Biology
Hélène RuffieuxArmand Valsesia
May 27, 2020
Open Access

Identification of tumor antigens in the HLA peptidome of patient-derived xenograft tumors in mouse

Molecular & Cellular Proteomics : MCP
Nataly Mancette RijenskyArie Admon
June 4, 2020
Open Access

Functional coupling of presequence processing and degradation in human mitochondria

The FEBS Journal
Cansu KücükköseFriederike-Nora Vögtle
June 3, 2020

Proteomic analysis revealed ROS-mediated growth inhibition of Aspergillus terreus by shikonin

Journal of Proteomics
Sonia K Shishodia, Jata Shankar
June 3, 2020

Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation

Urologic Oncology
Reza NabavizadehViraj A Master

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/proteotoxicity-to-inflammation/8cd199f0-9399-4f64-a09e-15887846f7cd